Skip to content

Assessment of Enhanced Recovery After Surgery Implementation at Pediatric Surgery Practices in Mainland China

Assessment of Enhanced Recovery After Surgery Implementation at Pediatric Surgery Practices in Mainland China: Based on a Survey of Performing Congenital Biliary Dilatation Operations

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05593861
Enrollment
66
Registered
2022-10-25
Start date
2021-07-01
Completion date
2022-07-21
Last updated
2022-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ERAS

Brief summary

Enhanced recovery after surgery (ERAS) is a new mode to optimize perioperative management, the core of which is to reduce perioperative physiological and psychological trauma and stress damage, and accelerate postoperative rehabilitation. ERAS has been gradually introduced in pediatric surgery in recent years, however, there are limited reports on its overall implementation. We aimed to determine the popularity of ERAS among pediatric populations in mainland China.

Detailed description

The application of ERAS in children with congenital biliary dilatation (CBD) was investigated. A total of 31 province-level administrative regions in mainland China were involved and each of them had at least one participating center. A questionnaire was designed to assess the baseline adherence of 17 recovery elements and chief pediatric surgeons at each center were invited to complete.

Interventions

None listed

Sponsors

Weibing Tang
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* chief pediatric surgeons at each center

Exclusion criteria

* Incomplete questionnaire

Design outcomes

Primary

MeasureTime frameDescription
Element adherenceimmediately after all the questionnaires are collectedAdherence to an element was determined if the frequency of practice reached specific thresholds as defined.

Secondary

MeasureTime frameDescription
Factors associated with baseline ERAS utilizationimmediately after all the questionnaires are collectedFactors associated with baseline ERAS utilization

Other

MeasureTime frameDescription
Barriers to implementationimmediately after all the questionnaires are collectedBarriers to implementation
Outcomes of concernimmediately after all the questionnaires are collectedOutcomes of concern

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026